Kāleka Hoʻāʻo Antigen SARS-CoV-2
Rapid 2019-nCoV IqG/IqM Combo Tost Cnrd ts nn •mmunoenromatOQraphy based one step in vitro tost It «d<>siQfi©d for tho fuptd Qualitative delmmlnMion of IflG nr>d IflM antitxxJios to 2019 SARS19 novel coronavirus -2) i ke kanaka somm mmA. ʻO ka holo holoʻokoʻa ʻo Rapid 2019-nCoV IgG/IgM Combo Tost Cnrd kahi mea e ʻike ai no ka COVID-19 BKpoctod infectod patents bosidot nudoic nod tost e hiki ke hoʻohiwahiwa i ka pololei o ka cieloction (a i ʻole COVID19).
HOOLAHA
ʻO ka "W coronnvirusos tx>lonq to tbo P genus COVID-19 H nn acute respiratory infoctous maʻi Poop«o om Oonocnlly suscoptiWo I kēia manawa, ʻo nā maʻi i loaʻa i ka novel coronavirus ma ke kumu nui o ka mfoebon. n^ywplomatic mfoefod poog cah E lilo hoʻi i kumu mfoebous ma ka ©p o kēia manawa
KUMU
Hoʻohana ka Rnpxl 2019-nCoV Combo Test Card i ka pnnoplo o immuno^nromotoflrap^y. Mqum ant>-human igM and mouse miti human igG Aniitxxlies nro immoeniizod on tho ntfroceHutose meentxane each, like two tost tines (laina igM aM IgG bno) ma ka puka aniani o ka mea hoao Ka laina IgM tn ka hoao wndew * ctoier i ʻO ka ʻumple pono i hoʻopili ʻia e IgG itnc E like me ka liʻiliʻi liʻiliʻi o ke kaona ma ka membrane i loko o ka mea hoʻāʻo IM ka 2019-nCoV recomt> nant 90M conjugate forms comptexes me kahi kikoʻī.
nntibodios (IgM a
ʻO ka loaʻa ʻole o ka pahu tg cokxed ma ka puka aniani hōʻike i kahi hopena hōʻike ne^at/vo A bwn-
NA MEA I HAAWIIA
1 Raprt 2019-nCoV IgG-lgM Kāleka Hoʻāʻo Combo
2 Laʻana pale
2 pL pipet capillary 4 Na kuhikuhi no ka hoohana ana
MAKEMAKEIA NA MEA KALAKA NEI
ʻO ka uaki a i ʻole ka manawa, nā lancets palekana, ka hoʻomākaukau ʻana i ka waiʻona
HOOLAHA
E mālama i ka hāmeʻa tost ma 4 a 30°C i loko o ka onflinnl soalod pouch Do Not Froozo.
Ka la hoopau ina >dicaie
Pono e waiho ʻia ka mea hana i loko o ka ʻeke kumu i hoʻopaʻa ʻia a hiki i ka mākaukau no ka hoʻohana ʻana. Ma hope o ka wehe ʻana, pono e hoʻohana koke ʻia ka mea hoʻāʻo. Mai hoohana hou i ka mea hana.
MAHELE
1 No ka 'oihana in vitro diagnostic uso wale no
2 ʻO ka huahana •$ stncUy no ka ʻoihana lapaʻau u$e wale nō i hoʻohana ʻia no ka hoʻohana pilikino.
3 Mai hoʻohana i ka huahana ma mua o ka lā exprsbon
4 Mai hana i ka hua ina ua txoken ka pou，$ darnaged a tM $«ai
5 E mālama i nā mea hoʻohālike a pau e like me ka maʻi maʻi
6 E hahai i ke kaʻina hana Lat> maʻamau aM tMOsafety fluxMhnet no a me ka hoʻolei ʻana i ka potemiaii/ infectious
mea Ke pau ke kaʻina hana hoʻāʻo, e hoʻokuʻu i nā mea hoʻohālike ma hope o ka autoclaving ma 121P kx ma ka liʻiliʻi o 20 min No ka mālama ʻana me 0 5% Sodium HypochJonte f
KA OHI ANA I KA HOOMAKAUKAU
1 Pono e hoʻopili ʻia ka serum, plasma a i ʻole ke koko holoʻokoʻa i nā kūlana iatxxatory maʻamau.
2 Heat inacbvatKX) o nā mea hoʻohālike, i hiki ke kumu i ka hemolyse a me ka denaturation proton, pono e pale ʻia.
3 Hana maikaʻi ka hoʻāʻo ʻana i ke koko holoʻokoʻa hou / serum i plasma samples Inā ʻaʻole hiki ke hoʻokō koke ʻia ka hoʻāʻo ʻana, hiki ke mālama ʻia ka serum I plasma ma 2-8°C a hiki i 3 mau lā inā (Way m testing No ka mālama lōʻihi, Hiki ke hoʻopaʻa ʻia nā speamens serum / plasma ma ・20*C a i ʻole 3 mahina a i ʻole ・70°C no ka lōʻihi o ka lōʻihi.
4 Hiki ke hoʻohui ʻia ʻo Sodium az>de ma ke ʻano he preservative a hiki i ka 0.1% me ka ʻole o ka hopena i nā hopena hōʻike.
